AFP and neoplasm: Prior therapy intensity is largely driven by defined risk stratification groups present at first diagnosis which consider Pretreatment Extent of Tumor (PRETEXT) group and associated annotation factors (multifocality, rupture, approximation to veins, extrahepatic extension), tumor histology, serum alpha-fetoprotein (AFP) levels, age, and metastases [6].